Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats

Clinical Science

Volumn 106, Issue 3, 2004, Pages 337-343

  Pereira, Leila M M ^a   Bezerra, Daniele G ^a   Machado, Denise L ^a   Mandarim de Lacerda, Carlos A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Enalapril; Heart; Hypertension; Kidney; Nitric oxide (NO); Stereology

Indexed keywords

ENALAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CELL COUNT; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART INJURY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CELL COUNT; ENALAPRIL; HYPERTENSION; KIDNEY GLOMERULUS; MALE; MYOCYTES, CARDIAC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED SHR;

EID: 1642297152     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030268     Document Type: Article

References (64)

1. Cohen, R. A. (1999) The potential clinical impact of 20 years of nitric oxide research. Am. J. Physiol. 276, H1404-H1407
2. Pechanova, O., Bernatova, I. and Babal, P. (1999) Structural alterations in the heart after long-term L-NAME and D-NAME treatment. Gen. Physiol. Biophys. 18 (Suppl. 1), 6-9
3. Holecyova, A., Torok, J., Bernatova, I. and Pechanova, O. (1996) Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension. Physiol. Res. 45, 317-321
4. Ribeiro, M. O., Antunes, E., Nucci, G., Lovisolo, S. M. and Zatz, R. (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20, 298-303
5. Maeso, R., Navarro-Cid, J., Rodrigo, E., Ruilope, L. M., Cachofeiro, V. and Lahera, V. (1999) Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME. J. Hypertens. 17, 221-227
6. Pessanha, M. G., Mandarim-de-Lacerda, C. A. and Dumas Hahn, M. (1999) Stereology and immunohistochemistry of the myocardium in experimental hypertension: long-term and low-dosage administration of inhibitor of the nitric oxide synthesis. Pathobiology 67, 26-33
7. Jover, B. and Mimran, A. (2001) Nitric oxide inhibition and renal alterations. J. Cardiovasc. Pharmacol. 38 (Suppl. 2), S65-S70
8. Pereira, L. M. and Mandarim-de-Lacerda, C. A. (2001) Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil. Anal. Quant. Cytol. Histol. 23, 330-338
9. Chappell, M. C., Diz, D. I., Yunis, C. and Ferrario, C. M. (1998) Differential actions of angiotensin-(1-7) in the kidney. Kidney Int. Suppl. 68, S3-S6
10. Dina, R. and Jafari, M. (2000) Angiotensin II-receptor antagonists: an overview. Am. J. Health Syst. Pharm. 57, 1231-1241
11. Taal, M. W. and Brenner, B. M. (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 57, 1803-1817
12. Lassila, M., Davis, B. J., Allen, T. J., Burrell, L. M., Cooper, M. E. and Cao, Z. (2003) Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Clin. Sci. 104, 341-347
13. Mandarim-de-Lacerda, C. A. and Pereira, L. M. (2001) Volume-weighted mean nuclear volume and numerical nuclear density in the cardiomyocyte following enalapril and verapamil treatment. Virchows Arch. 438, 92-95
14. Pereira, L. M. and Mandarim-de-Lacerda, C. A. (2001) The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition. Int. J. Exp. Pathol. 82, 115-122
15. Pereira, L. M. and Mandarim-de-Lacerda, C. A. (2001) Glomerular profile numerical density per area and mean glomerular volume in rats submitted to nitric oxide synthase blockade. Histol. Histopathol. 16, 15-20
16. Garg, J., Messerli, A. W. and Bakris, G. L. (2002) Evaluation and treatment of patients with systemic hypertension. Circulation 105, 2458-2461
17. Scherle, W. (1970) A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57-60
18. Weibel, E. R. (1979) Stereological Methods: Practical Methods for Biological Morphometry, Academic Press, London
19. Carson, F. L., Martin, J. H. and Lynn, J. A. (1973) Formalin fixation for electron microscopy: a re-evaluation. Am. J. Clin. Pathol. 59, 365-373
20. Sterio, D. C. (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134, 127-136
21. Gundersen, H. J. G. (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111, 219-227
22. Cruz-Orive, L. M. and Weibel, E. R. (1990) Recent stereological methods for cell biology: a brief survey. Am. J. Physiol. 258, L148-L156
23. Gundersen, H. J., Bagger, P., Bendtsen, T. F. et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857-881
24. Mandarim-de-Lacerda, C. A. (1999) What is the interest of normal and pathological morphological research to be quantitative? The example of the stereology. Braz. J. Morphol. Sci. 16, 131-139
25. Baddeley, A. J., Gundersen, H. J. and Cruz-Orive, L. M. (1986) Estimation of surface area from vertical sections. J. Microsc. 142, 259-276
26. Nyengaard, J. R. (1999) Stereologic methods and their application in kidney research. J. Am. Soc. Nephrol. 10, 1100-1123
27. Gundersen, H. J. and Jensen, E. B. (1985) Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J. Microsc. 138, 127-142
28. Sorensen, F. B. (1991) Stereological estimation of the mean and variance of nuclear volume from vertical sections. J. Microsc. 162, 203-229
29. Zar, J. H. (1999) Biostatistical Analysis, Prentice-Hall, Upper Saddle River
30. Matsuoka, H., Nakata, M., Kohno, K. et al. (1996) Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27, 14-18
31. Rees, D. D., Palmer, R. M. and Moncada, S. (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86, 3375-3378
32. Pereira, L. M., Vianna, G. M. and Mandarim-de-Lacerda, C. A. (1998) Stereology of the myocardium in hypertensive rats. Differences in relation to the time of inhibition of nitric oxide synthesis. Virchows Arch. 433, 369-373
33. i regulatory mechanisms. Hypertension 31, 961-967
34. Black, M. J., Bertram, J. F. and Johnston, C. I. (2001) Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat. J. Hypertens. 19, 785-794
35. Simko, F. and Simko, J. (1999) Heart failure and angiotensin converting enzyme inhibition: problems and perspectives. Physiol. Res. 48, 1-8
36. Ferdinand, K. C. (2001) Update in pharmacologic treatment of hypertension. Cardiol. Clin. 19, 279-294
37. Rizzoni, D., Porteri, E., Piccoli, A. et al. (1998) Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 32, 305-310
38. Kahan, T. (1998) The importance of left ventricular hypertrophy in human hypertension. J. Hypertens. 16 (Suppl.), S23-S29
39. Anversa, P., Leri, A., Kajstura, J. and Nadal-Ginard, B. (2002) Myocyte growth and cardiac repair. J. Mol. Cell. Cardiol. 34, 91-105
40. Takemoto, M., Egashira, K., Usui, M. et al. (1997) Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99, 278-287
41. Buja, L. M., Eigenbrodt, M. L. and Eigenbrodt, E. H. (1993) Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 117, 1208-1214
42. Mandarim-de-Lacerda, C. A. and Pereira, L. M. (2000) Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology 68, 36-42
43. Pessanha, M. G. and Mandarim-de-Lacerda, C. A. (2000) Influence of the chronic nitric oxide synthesis inhibition on cardiomyocytes number. Virchows Arch. 437, 667-674
44. Zorzi, R. L. A., Pereira, L. M. M. and Mandarim-de-Lacerda, C. A. (2002) Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade. J. Cell. Mol. Med. 6, 599-608
45. Aguila, M. B., Mandarim-de-Lacerda, C. A. and Apfel, M. I. (1998) Stereology of the myocardium in young and aged rats. Arq. Bras. Cardiol. 70, 105-109
46. Youn, T. J., Kim, H. S., Kang, H. J. et al. (2001) Inhibition of nitric oxide synthesis increases apoptotic cardiomyocyte death and myocardial angiotensin-converting enzyme gene expression in ischemia/reperfusion-injured myocardium of rats. Heart Vessels 16, 12-19
47. Buzello, M., Boehm, C., Orth, S. et al. (2003) Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension. Virchows Arch. 442, 364-371
48. Li, Z., Bing, O. H., Long, X., Robinson, K. G. and Lakatta, E. G. (1997) Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am. J. Physiol. 272, H2313-H2319
49. Backlund, T., Palojoki, E., Saraste, A. et al. (2003) Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Cardiovasc. Res. 57, 727-737
50. Tamura, T., Said, S., Lu, W. et al. (2000) Is apoptosis present in progression to chronic hypertensive heart failure? J. Card. Fail. 6, 37-42
51. Susic, D. (2000) Renal protective potential of antihypertensive drugs. Exp. Opin. Invest. Drugs 9, 2593-2600
52. Ono, H., Ono, Y. and Frohlich, E. D. (1995) Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics. Hypertension 26, 249-255
53. Kost, Jr, C. K., Li, P., Williams, D. S. and Jackson, E. K. (1998) Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats. J. Cardiovasc. Pharmacol. 31, 854-861
54. Anderson, S. and Brenner, B. M. (1986) Effects of aging on the renal glomerulus. Am. J. Med. 80, 435-442
55. Zoja, C., Donadelli, R., Corna, D. et al. (1997) The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am. J. Kidney Dis. 29, 254-264
56. Childs, T. J., Adams, M. A. and Mak, A. S. (1990) Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 16, 662-668
57. Kett, M. M., Alcorn, D., Bertram, J. F. and Anderson, W. P. (1995) Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats. Hypertension 25, 335-342
58. Brilla, C. G., Matsubara, L. and Weber, K. T. (1996) Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension 28, 269-275
59. Mitchell, G. F., Pfeffer, M. A., Finn, P. V. and Pfeffer, J. M. (1996) Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circulation 94, 2923-2929
60. Ono, H., Ono, Y. and Frohlich, E. D. (1996) ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension 27, 176-183
61. Francischetti, A., Ono, H. and Frohlich, E. D. (1998) Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME. Hypertension 31, 795-801
62. Susic, D., Varagic, J. and Frohlich, E. D. (1999) Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats. J. Hypertens. 17, 1209-1215
63. Saleh, F. H. and Jurjus, A. R. (2001) A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker. J. Pathol. 193, 415-420
64. ω-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 40, 789-800